All Achievements
activity Management of Elderly AML
activity ASH 2015 highlights in acute myeloid leukemia
activity Trends in clinical development in myelodysplastic syndromes
activity Myelodysplastic syndromes: Challenges of second
activity Supportive care for myelodysplastic syndromes in 2015 line treatments
activity Outcome of patients treated for MDS after failure of lenalidomide therapy
activity Current treatment strategies in MDS
activity MDS: State of the art in 2014
activity High risk MDS: Clinical management after frontline treatment failure
activity Chemo-genomic approaches in AML
activity Second line treatments in high risk MDS
activity Elderly high risk MDS: treatment options and supportive care recommendations
activity Ongoing and futures trials in myelodysplastic syndromes
activity AML 2013: State of the art” and “MDS 2013: state of the art
activity Investigational approaches in high risk MDS: second line treatments
activity High risk MDS: second line options
activity Cancer biomarkers and woman fertility preservation
activity Implication of PTK7 receptor in AML
activity Outcome of MDS patients with hypomethylating agent failure
activity Clinical trials in myelodysplastic syndromes